As diabetes care continues to be a crucial focus, new treatments are appearing . Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy generation in GLP-1 receptor agonist medications. While all https://linkingbookmark.com/story22039621/the-new-drug-vs-that-medication-vs-semaglutide-a-head-to-head-analysis